» Articles » PMID: 30398038

Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data

Overview
Specialty Endocrinology
Date 2018 Nov 7
PMID 30398038
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A number of studies have reported future prevalence estimates for diabetes mellitus (DM), but these studies have been limited for the Korean population. The present study aimed to construct a forecasting model that includes risk factors for type 2 DM using individual- and national-level data for Korean adults to produce prevalence estimates for the year 2030.

Methods: Time series data from the Korea National Health and Nutrition Examination Survey and national statistics from 2005 to 2013 were used. The study subjects were 13,908 male and 18,697 female adults aged 30 years or older who were free of liver cirrhosis. Stepwise logistic regression analysis was used to select significant factors associated with DM prevalence.

Results: The results showed that survey year, age, sex, marital, educational, or occupational status, the presence of obesity or hypertension, smoking status, alcohol consumption, sleep duration, psychological distress or depression, and fertility rate significantly contributed to the 8-year trend in DM prevalence (<0.05). Based on sex-specific forecasting models that included the above factors, DM prevalence for the year 2030 was predicted to be 29.2% (95% confidence interval [CI], 27.6% to 30.8%) in men and 19.7% (95% CI, 18.2% to 21.2%) in women.

Conclusion: The present study projected a two-fold increase in the prevalence of DM in 2030 compared with that for the years 2013 and 2014 in Korean adults. Modifiable factors contributing to this increase in DM prevalence, such as obesity, smoking, and psychological factors, may require attention in order to reduce national and individual costs associated with DM.

Citing Articles

GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions.

Yu J, Park S, Lee D, Kim N, Seo J Kidney Res Clin Pract. 2022; 41(2):136-149.

PMID: 35391537 PMC: 8995488. DOI: 10.23876/j.krcp.22.001.


Associations between obesity, metabolic syndrome, and endometrial cancer risk in East Asian women.

Park B J Gynecol Oncol. 2022; 33(4):e35.

PMID: 35320886 PMC: 9250850. DOI: 10.3802/jgo.2022.33.e35.


Spironolactone Attenuates Methylglyoxal-induced Cellular Dysfunction in MC3T3-E1 Osteoblastic Cells.

Park S, Suh K, Jung W, Chin S J Korean Med Sci. 2021; 36(38):e265.

PMID: 34609092 PMC: 8490790. DOI: 10.3346/jkms.2021.36.e265.


Antiobesity and Antidiabetic Effects of Powder Intake in High-Fat Diet-Induced Obese C57BL/6 Mice.

Jung J, Hwang S, Park H, Jin G, Lee B Evid Based Complement Alternat Med. 2021; 2021:5587848.

PMID: 34257685 PMC: 8257357. DOI: 10.1155/2021/5587848.


A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial.

Lee M, Lee D, Ahn H, Park C JMIR Mhealth Uhealth. 2021; 9(2):e17573.

PMID: 33625363 PMC: 7946585. DOI: 10.2196/17573.


References
1.
Sozmen K, Unal B, Capewell S, Critchley J, Oflaherty M . Estimating diabetes prevalence in Turkey in 2025 with and without possible interventions to reduce obesity and smoking prevalence, using a modelling approach. Int J Public Health. 2014; 60 Suppl 1:S13-21. DOI: 10.1007/s00038-014-0622-2. View

2.
Koska J, Stefan N, Votruba S, Smith S, Krakoff J, Bunt J . Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring). 2008; 16(9):2003-9. PMC: 2692524. DOI: 10.1038/oby.2008.292. View

3.
Cappuccio F, DElia L, Strazzullo P, Miller M . Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2009; 33(2):414-20. PMC: 2809295. DOI: 10.2337/dc09-1124. View

4.
Javanbakht M, Mashayekhi A, Baradaran H, Haghdoost A, Afshin A . Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis. PLoS One. 2015; 10(7):e0132505. PMC: 4511591. DOI: 10.1371/journal.pone.0132505. View

5.
Holman N, Forouhi N, Goyder E, Wild S . The Association of Public Health Observatories (APHO) Diabetes Prevalence Model: estimates of total diabetes prevalence for England, 2010-2030. Diabet Med. 2011; 28(5):575-82. DOI: 10.1111/j.1464-5491.2010.03216.x. View